A B S T R A C T Aryl hydrocarbon hydroxylase induction was studied in cultured peripheral blood lymphocytes and pulmonary alveolar macrophages from 15 smokers and 8 nonsmokers with a variety of pulmonary diseases. Enzyme levels in lymphocytes from cigarette smokers cultured in medium without an inducing agent were 57±6 mU/106 cells (mean+SEM), while enzyme levels in lymphocytes from nonsmokers were 20+2 mU/106 cells (P < 0.001). When lymphocytes were cultured in the presence of the inducing agent, benzo-(a)anthracene, enzyme activity was increased to 168 +23 mU/106 cells in smokers' cells and 99+22 mU/106 cells in lymphocytes from nonsmokers (P < 0.04).
A B S T R A C T Aryl hydrocarbon hydroxylase induction was studied in cultured peripheral blood lymphocytes and pulmonary alveolar macrophages from 15 smokers and 8 nonsmokers with a variety of pulmonary diseases. Enzyme levels in lymphocytes from cigarette smokers cultured in medium without an inducing agent were 57±6 mU/106 cells (mean+SEM), while enzyme levels in lymphocytes from nonsmokers were 20+2 mU/106 cells (P < 0.001). When lymphocytes were cultured in the presence of the inducing agent, benzo-(a)anthracene, enzyme activity was increased to 168 +23 mU/106 cells in smokers' cells and 99+22 mU/106 cells in lymphocytes from nonsmokers (P < 0.04).
When noninduced enzyme values in cultured macrophages were compared, smokers' cells had enzyme levels of 45+5 mU/106 cells, whereas nonsmokers had enzyme activity of 24±2 mU/106 cells (P < 0.002). However, pulmonary macrophages from smokers or nonsmokers, cultured in the presence of benzo(a)-anthracene, had similar levels of induced enzyme activity (P > 0.1). A positive correlation was observed for nonsmokers (r = 0.596, P > 0.1 <0.2) or smokers (r = 0.640, P < 0.04), when enzyme values for noninduced cultures of macrophages and lymphocytes from individual patients were simultaneously compared. Enzyme values for macrophages and lymphocytes cultured in the presence of an inducer also revealed a positive correlation for individual smokers (r = 0.801, P < 0.001) or nonsmokers (r = 0.785, P < 0.01). Inducibility (expressed as fold-induction) for macrophages INTRODUCTION Aryl hydrocarbon hydroxylase (AHH)l is an inducible, monooxygenase complex localized in the endoplasmic reticulum of many body tissues (1) (2) (3) (4) (5) . By hydroxylation, AHH converts lipophilic polycyclic aromatic hydrocarbons (e.g. benzo(a)pyrene and benzo(a)-anthracene [BA] ) into more polar, water-soluble compounds that are eliminated from the body. During hydroxylation, intermediate compounds with enhanced mutagenic (6) (7) (8) (9) (10) and carcinogenic (11, 12) activities are formed. Large quantities of AHH may be harmful to cigarette smokers through increased production of these potent intermediate compounds from the polycyclic hydrocarbons present in cigarette smoke. Since capacity for induction of AHH might be genetically determined in both animals (13) (14) (15) and man (16, 17) , individual variation in the production of this enzyme could be important in modifying an individual's risk of developing lung cancer.
When the cultured peripheral blood lymphocyte has been used as the test cell, variability and intraindividual fluctuation of AHH inducibility (17) have hindered attempts to investigate the possible associa1Abbreviations used in this paper: AHH, aryl hydrocarbon hydroxylase; BA, benzo(a)anthracene; PAM, pulmonary alveolar macrophage. Investigation Volume 60 November 1977 -1017-1024   1017 tion previously reported between levels of AHH and the development of lung cancer (18) . Comparison of AHH activity in more than one tissue from an individual has proved more satisfactory for the investigation of the capacity for AHH induction (19, 20) . In addition to lymphocytes, we have selected the pulmonary alveolar macrophage (PAM) as another tissue that can be used to measure AHH inducibility. These cells, directly exposed to cigarette smoke in the lungs of smokers, are obtainable by broncho-alveolar lavage (5) . Since AHH is inducible in cultured human PAMs by either cigarette smoke extracts (21) or BA (22) , these cells are suitable for determining in vitro AHH inducibility.
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Comparison of AHH levels in freshly lavaged PAMs with the degree of induction of AHH in cultured lymphocytes has revealed a positive correlation between values for these different cells from individual healthy volunteers (19) or patients without cancer (20) . In contrast, values for AHH in these cells from cancer patients were dissociated (20) . In the present study, we compare in vitro inducibility of AHH in PAMs and peripheral blood lymphocytes from patients with a variety of nonneoplastic lung diseases. When studied in cultured cells, similar AHH values were observed for PAMs and lymphocytes from smokers or nonsmokers. Good correlations were noted for individual PAM and lymphocyte AHH values, suggesting that inducibility of the enzyme in these two types of cells is similar.
METHODS
Study subjects. Peripheral blood lymphocytes and PAMs were obtained from 23 patients (6 females and 17 males) ranging in age from 21 to 69 yr (mean 44 yr). Patients included 8 nonsmokers and 15 cigarette smokers. An individual was classified as a nonsmoker if he or she had not smoked tobacco for 6 mo or more before the study, a period selected because previous studies indicated that AHH activity in PAMs elevated by cigarette smoking reverts to lower nonsmoker levels within 3 mo of terminating smoking (5). Only two of the nonsmokers were former smokers; both had stopped smoking 1 yr before study.
None of the patients were diagnosed as having cancer, but they didLhave a variety of nonneoplastic lung disordeqrs, including four with pulmonary tuberculosis, three with pulmonary abscess, six with chronic pneumonia, two with sarcoidosis, one with interstitial fibrosis, and seven with hemoptysis of undertermined origin. Before the collection of samples, the study was explained to all subjects and written informed consent was obtained on a form approved by the Baylor Institutional Review Board. All patients were on normal institutional diets at the time of this study. Hospital charts were carefully screened to be sure patients were not receiving medications that might be expected to alter their AHH levels.
Preparation of PAMs. PAMs were obtained during diagnostic bronchoscopy as previously described, employing saline lavage with 50-100 ml sterile 0.15 M NaCl through an Olympus 5-B2 fiberoptic bronchoscope (Olympus Corporation of America, New Hyde Park, N. Y.) (5) . PAMs (representing 80-95% of the total number of cells obtained) were separated by centrifugation, washed, and resuspended at a known concentration in Joklick's modified minimum essential medium (GIBCO F-13, Grand Island Biological Co., Grand Island, N. Y.) prepared with ultrapure water (Harleco, Gibbstown, N. J.) and supplemented with 10% fetal calf serum, heparin (10 U/ml), phytohemaglutinin (10 ml/liter), and pokeweed mitogen (10 ml/ liter). 106 cells were placed in culture vials containing 5 ml of this medium and cultured for 24 h, as previously described, with and without addition of 10 ,um of the inducer, BA (22) .
1-2 x 106 PAMs were placed in culture vials containing 2 ml of the medium and were assayed in triplicate on the day of collection to determine fresh cell AHH activity.
Preparation of lymphocyte cultures. Mononuclear cells were separated from 10 ml venous blood by Ficoll-Hypaque sedimentation (23) . Cells were washed with heparinized saline (10 U/ml), resuspended in the medium described above, and quantitated using a model ZBI Coulter Counter (Coulter Electronics, Inc., Hialeah, Fla.). Differential counts were made from slides stained with Wright-Giemsa stain (85-92% of the cells obtained were lymphocytes). Cells were then cultured with and without 10 ,uM BA for 96 h at 37°C in a mixture of CO2 and air, as previously described (20, 21) . Fluorometric analysis of AHH. The method for fluorometric measurement of AHH in PAMs and lymphocytes has been previously reported (20, 21) . AHH activity is expressed in milliunits per 106 cells, where 1 U is the amount of fluorescence equivalent to the production of 1 To determine whether a relationship exists between AHH levels in cultured PAMs and lymphocytes from individual smokers or nonsmokers, values for both cell types, cultured without an inducing agent in the medium, were compared (Fig. 3) . Values for cells from individual cigarette smokers exhibited a good correlation (r = 0.640, P < 0.04) as did values for individual nonsmokers (r = 0.596, P > 0.1 < 0.2). When a similar comparison was performed between levels of AHH in BA-induced PAMs and lymphocytes from individual patients (Fig. 4) (Fig. 6 ), values observed for nonsmokers (r = 0.889, P < 0.001) and for cigarette smokers (r = 0.948, P < 0.001) were similar. The number of subjects studied is too small to allow any meaningful conclusions to be drawn concerning the distribution within the patient population of individuals with high or low AHH inducibility. However (26) , and pulmonary alveolar macrophages (5, (19) (20) (21) (22) . Where values for PAMs and lymphocytes from the same individuals were available, the capacity for AHH induction in these two tissues was similar (19, 20 Lymphocyte Delta-induction (milliunits/106cells 1 FIGURE 5 Comparison of the increment in AHH between noninduced and BA-induced (delta induction) in cultured PAMs and lymphocytes from the same individual (r = 0.835, P < 0.001 for smokers and r = 0.719, P < 0.03 for nonsmokers). Lymphocyte Fold-induction FIGURE 6 Comparison of values for AHH (expressed as foldinduction) in cultured PA.\Ms and lymphocytes from individual patients (r = 0.948, P < 0.001 for smokers and r = 0.889, P < 0.001 for nonsmokers).
entry (5, 19, 20) , but also in remote tissuies, such as placenta (25) . Induction of AHH in cultured cells has been studied with a variety of different inducing agents. The enzyme can be induced in vitro by cigarette tar extracts (21) , or by individual polycyclic aromatic hydrocarbons, such as 3-methylcholanthrene (1) or BA (20) , components of cigarette smoke. In the present study, when levels of AHH were measured in noninduced cultures of either lymphocytes or PAMs, levels were consistently higher when the cells came from smokers than from nonsmokers. In addition, when lymphocytes were cultured with BA to further induce AHH activity, significantly higher values were obtained for cells from smokers than from nonsmokers. Levels of AHH in BA-induced cultures of PAMs also tended to be higher when cells came from cigarette smokers, but the increases were not statistically significant.
The elevated levels of AHH in cells from smokers might be the result of persistence of polycyclic hydrocarbons in the cells during culture, or could result from the action of other classes of compounds capable of inducing AHH. This supports a report indicating that unidentified compounds present in cigarette smoke can induce the AHH system by a different biochemical pathway from the one utilized by the polycyclic aromatic hydrocarbons (27) . In the case of lymphocytes, a clone or more responsive cells may have been stimulated by cigarette smoking. Elevated AHH activity persists in PAMs during shortterm culture, perhaps because these are metabolically (Figs. 3 and 4) or whether the data were expressed as induction of AHH (Figs. 5 and 6 ). The benefit of retaining the concept of fold-induction was accentuated by the observation that values for both smokers and nonsmokers had strikingly similar distribution when AHH inducibilities in cultured PAMs and lymphocytes were compared (Fig. 6) .
This study represents the first time that cells from two separate tissues from individual subjects have been shown to possess similar AHH induction capabilities when tested under identical culture conditions. The observation that the degree of inducibility of AHH in humans varies with the individual and that the capacity for AHH induction can be confirmed by measurement in several different types of cells agrees with animal studies in which AHH induction was similar for different nonhepatic tissues from the same animal (28) .
Although the levels of AHH in healthy individuals were not measured in the present study, similar AHH activity should be observed in cultured PAMs or lymphocytes from patients without cancer or healthy volunteers. This is supported by other investigators that have demonstrated that levels of AHH in fresh PAMs and the inducibility of the enzyme in cultured lymphocytes are positively correlated for individual normal healthy volunteers (19) or individual patients without evidence of cancer (20) , and the range of AHH values for both groups is similar. Studies designed to investigate AHH activity in cultured PAMs and lymphocytes from healthy volunteers will be necessary, however, before definite conclusions can be drawn.
When induction of AHH was studied in cultured lymphocytes, lung cancer patients exhibited higher lymphocyte AHH inducibility than individuals without lung cancer (18) . The postulated mechanisms for a possible increased risk of chemical carcinogenesis in cigarette smokers with high levels of AHH concern the production during metabolism and/or remetabolism of the polycyclic aromatic hydrocarbons in cigarette smoke to intermediate products of high mutagenic (6) (7) (8) (9) (10) and carcinogenic (11) (12) potential. In addition to differences in the generation of metabolites, another critical factor in determining susceptibility to carcinogens might be individual variation in the affinity of binding of these metabolites to DNA (24) .
An additional function ofthe AHH system in the liver is the metabolism of xenobiotic drugs (29 (19, 20) . In the present series, AHH values for cultured as well as fresh PAMs were measured for each individual. This expands the number of comparisons possible on AHH values for PAMs and lymphocytes from individual subjects. By increasing the comparisons for a given individual, some of the day-to-day variation-in AHH values observed when lymphocytes alone are used to measure individual enzyme induction capacity (17) might be eliminated.
The methods employed in the present study for evaluating PAM and lymphocyte AHH might provide a satisfactory approach for distinguishing abnormalities in AHH induction in lung cancer patients (20) . In addition, analyzing levels of AHH in separate tissues from the same individual could provide a mechanism for studying the biochemical pathways responsible for the previously reported (but unexplained) dissociation of PAM and lymphocyte AHH values in individuals with lung cancer (20) .
By measuring AHH in separate tissues from the same individual, problems previously encountered in using a single tissue for analysis of an individual's AHH characteristics might be resolved. This added dimension for the analysis of AHH in individuals might also provide researchers with another tool for evaluating the relationship ofAHH to chemical carcinogenesis in the lungs of cigarette smokers.
